Plain-English translation of NCT04941794 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →This is an observational study that follows people with type 2 diabetes to understand which blood markers and heart test results can predict who will develop heart disease. Researchers will take regular measurements over time—including heart imaging, electrical heart readings, blood tests, and a walking test—to identify early warning signs before heart problems start.
People with type 2 diabetes are at higher risk for heart disease, but doctors currently don't have a reliable way to predict who will develop it. This study aims to find specific blood markers and test results that could help doctors identify at-risk patients earlier, when treatment might help prevent serious heart problems.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic at the start of the study and then once per year for follow-up appointments. At each visit, you'll have your heart checked with an ultrasound, a heart electrical recording (ECG), several blood tests, and a simple 6-minute walking test. The study tracks you over time to see which measurements best predict who develops heart problems.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Denmark
Enrollment target
~500 participants
Started
July 2021
Primary completion
July 2027
Age range
50 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Peter Leutscher, Professor
Department of Cardiology
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.